| SpectraBase Spectrum ID |
8FMx0wUiVyy |
| Name |
1-(4-Bromobenzyl)-4-(2-hydroxyethyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
298.068076239 u |
| Formula |
C13H19BrN2O |
| InChI |
InChI=1S/C13H19BrN2O/c14-13-3-1-12(2-4-13)11-16-7-5-15(6-8-16)9-10-17/h1-4,17H,5-11H2 |
| InChIKey |
ZEYMJAPCVCOFKR-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
299.212 g/mol |
| Nominal Mass |
298 u |
| Quality |
904 |
| Retention Index |
2115 |
| SMILES |
OCCN1CCN(CC=2C=CC(=CC2)Br)CC1 |
| SPLASH |
splash10-01b9-9680000000-4e1e5fa55de1cdb19067 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(4-bromobenzyl)-4-(2-hydroxyethyl)
2-(4-(4-bromobenzyl)piperazin-1-yl)ethan-1-ol |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011235 |
